ArticleFrontiers in pharmacology2017

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

Greta Garrido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.